https://www.selleckchem.com/products/dmx-5084.html
023, 95% CI; 1.006-1.040, p=0.007) or a categorical variable (HR; 1.513, 95% CI; 1.073-2.134, p=0.018), FIGO stage, cell type, and the number of cycles of chemotherapy received during CCRT were significant independent prognostic factors for overall survival. A shorter waiting time from pathological diagnosis to definitive CCRT showed benefit on overall survival. Our findings suggest that an effort to minimize waiting times should be recommended in cervical cancer patients who are candidates for CCRT. A shorter waiting time from patholo
Like
Comment
Share
